-
The authors sought to estimate trends in prenatal drug exposure and neonatal abstinence syndrome (NAS) in Washington State from 2000 to 2008.
-
You've seen her before. she's often young and partnered, but might be midlife and changing the status of her relationship. Sometimes she presents for an annual exam and mentions her pain later during the visit. Occasionally she actually presents with the complaint of dyspareunia.
-
Gestational diabetes (gdm) now complicates about one in 15 pregnancies, but, undoubtedly, the prevalence will increase even further if we cannot curb the concerning rise in obesity in this country.
-
-
The authors assessed the risk of venous thrombosis (vt) in current users of non-oral hormonal contraception using four national registries in Denmark.
-
Secondary Prevention of Lacunar Stroke; Quality-of-life Effects of PSA Screening; PSA Elevations After Prostate Cancer Radiotherapy; Attenuated CV Benefits of Clopidogrel in Diabetes; Is A1c Always the Best Game in Town to Monitor Type 2 Diabetes?
-
In this issue: Dementia and benzodiazepines; effectiveness of omega-3 fatty acid and Ginkgo biloba supplements; and FDA actions.
-
Although the incidence of hysterectomy has declined in recent years, it remains the most common major gynecologic procedure, and many women are offered or consider elective bilateral oophorectomy (BSO) at the time of hysterectomy to reduce ovarian cancer risk.
-
Mediators of the autonomic response to stress, such as the catecholamines norepinephrine and epinephrine, promote cancer growth, metastasis, and progression in preclinical models.
-
Between September 1, 1987, and January 31, 2001, a total of 4047 obese persons were enrolled in the Swedish Obesity Study (SOS) intervention trial.